Literature DB >> 8163990

Localisation and characterisation of dystrophin in the central nervous system of controls and patients with Duchenne muscular dystrophy.

M Uchino1, H Teramoto, H Naoe, K Yoshioka, T Miike, M Ando.   

Abstract

The aim was to localise and characterise dystrophin in various human tissues, especially in the CNS. Immunoblotting and immunostaining studies were carried out with eight region-specific dystrophin antibodies. In necropsy tissue from controls, dystrophin was noted as a doublet in immunoblots of striated muscle, and as a single band in those of smooth muscle and the CNS. With immunostaining, punctate immunoreactivity was seen on the cell bodies and dendrites of the cerebral cortical neurons and cerebellar Purkinje cells. By contrast, dystrophin was not detected in any tissues, including the cerebrum and cerebellum, of patients with Duchenne muscular dystrophy who had an intellectual disturbance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163990      PMCID: PMC1072870          DOI: 10.1136/jnnp.57.4.426

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  27 in total

1.  Central nervous system manifestations in childhood muscular dystrophy (CMD). I. Psychometric and electroencephalographic findings.

Authors:  H Zellweger; E Niedermeyer
Journal:  Ann Paediatr       Date:  1965

2.  Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons.

Authors:  H G Lidov; T J Byers; S C Watkins; L M Kunkel
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

3.  Identification of a chromosome 6-encoded dystrophin-related protein.

Authors:  T S Khurana; E P Hoffman; L M Kunkel
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

Review 4.  Dystrophin: a clinical perspective.

Authors:  H B Wessel
Journal:  Pediatr Neurol       Date:  1990 Jan-Feb       Impact factor: 3.372

5.  Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in nonmuscle tissues.

Authors:  J P Hugnot; H Gilgenkrantz; N Vincent; P Chafey; G E Morris; A P Monaco; Y Berwald-Netter; A Koulakoff; J C Kaplan; A Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

6.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

Authors:  M Koenig; A H Beggs; M Moyer; S Scherpf; K Heindrich; T Bettecken; G Meng; C R Müller; M Lindlöf; H Kaariainen; A de la Chapellet; A Kiuru; M L Savontaus; H Gilgenkrantz; D Récan; J Chelly; J C Kaplan; A E Covone; N Archidiacono; G Romeo; S Liechti-Gailati; V Schneider; S Braga; H Moser; B T Darras; P Murphy; U Francke; J D Chen; G Morgan; M Denton; C R Greenberg; K Wrogemann; L A Blonden; M B van Paassen; G J van Ommen; L M Kunkel
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

7.  Localization and characterization of dystrophin in muscle biopsy specimens from Duchenne muscular dystrophy and various neuromuscular disorders.

Authors:  M Uchino; S Araki; T Miike; H Teramoto; T Nakamura; T Yasutake
Journal:  Muscle Nerve       Date:  1989-12       Impact factor: 3.217

8.  A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues.

Authors:  D Lederfein; Z Levy; N Augier; D Mornet; G Morris; O Fuchs; D Yaffe; U Nudel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

9.  Ultrastructural localization of dystrophin in human muscle by using gold immunolabelling.

Authors:  M J Cullen; J Walsh; L V Nicholson; J B Harris
Journal:  Proc R Soc Lond B Biol Sci       Date:  1990-05-22

10.  The subcellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle.

Authors:  T J Byers; L M Kunkel; S C Watkins
Journal:  J Cell Biol       Date:  1991-10       Impact factor: 10.539

View more
  7 in total

1.  Increased density of dystrophin protein in the lateral versus the vermal mouse cerebellum.

Authors:  Wanda M Snow; Mark Fry; Judy E Anderson
Journal:  Cell Mol Neurobiol       Date:  2013-02-23       Impact factor: 5.046

2.  Effects of Sildenafil on Cerebrovascular Reactivity in Patients with Becker Muscular Dystrophy.

Authors:  Ulrich Lindberg; Nanna Witting; Stine Lundgaard Jørgensen; John Vissing; Egill Rostrup; Henrik Bo Wiberg Larsson; Christina Kruuse
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

3.  Selective deficits in verbal working memory associated with a known genetic etiology: the neuropsychological profile of duchenne muscular dystrophy.

Authors:  V J Hinton; D C De Vivo; N E Nereo; E Goldstein; Y Stern
Journal:  J Int Neuropsychol Soc       Date:  2001-01       Impact factor: 2.892

4.  Poor verbal working memory across intellectual level in boys with Duchenne dystrophy.

Authors:  V J Hinton; D C De Vivo; N E Nereo; E Goldstein; Y Stern
Journal:  Neurology       Date:  2000-06-13       Impact factor: 9.910

5.  Investigation of Poor Academic Achievement in Children with Duchenne Muscular Dystrophy.

Authors:  V J Hinton; D C De Vivo; R Fee; E Goldstein; Y Stern
Journal:  Learn Disabil Res Pract       Date:  2004-08

Review 6.  Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy.

Authors:  Kasia Dzierlega; Toshifumi Yokota
Journal:  Gene Ther       Date:  2020-06-01       Impact factor: 5.250

7.  Neural integrity is maintained by dystrophin in C. elegans.

Authors:  Shan Zhou; Lihsia Chen
Journal:  J Cell Biol       Date:  2011-01-17       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.